Q: (IAS/2021)
question_subject:
Current Affairs
question_exam:
IAS
stats:
0,109,96,61,11,127,6
keywords:
{'recombinant vector vaccines': [0, 0, 0, 1], 'vaccines': [0, 0, 0, 1], 'vectors': [1, 0, 0, 2], 'genetic engineering': [0, 0, 0, 2], 'viruses': [2, 0, 0, 4]}
Both statements 1 and 2 are correct. Recombinant vector vaccines are developed using genetic engineering techniques, where a harmless virus or bacteria is used as a vector to deliver a piece of genetic material from the target pathogen into the body, thus triggering an immune response against the target pathogen.